about
Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTRAlternative polyadenylation of cyclooxygenase-2.Regulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanismsPotential use of COX-2-aromatase inhibitor combinations in breast cancerThe cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risksCyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1Regulation of COX-2 expression by miR-146a in lung cancer cellsBiochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia.Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.Current concepts in cyclooxygenase inhibition in breast cancer.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Role of cyclooxygenase-2 in the control of renal haemodynamics and excretory function.Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.COX-2 inhibition: a possible role in the management of prostate cancer?Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical ProstatectomyModulation of signaling pathways in prostate cancer by green tea polyphenols.Increased dietary sodium induces COX2 expression by activating NFκB in renal medullary interstitial cells.Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer.Cyclooxygenase metabolites in the kidney.The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts.Focal adhesion kinase signaling regulates anti-inflammatory function of bone marrow mesenchymal stromal cells induced by biomechanical force.Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis.Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production.Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner.Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression.15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line.Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression.Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase.Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells.Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase.Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism.Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades
P2860
Q24670536-1A30EE57-BDDD-426B-8800-B14FFA235CF2Q24798039-C1980A4B-FE69-4CE1-B99D-222CEB5C988BQ26849624-608D1F9B-4027-4BAD-826D-C2532B4D1949Q28187414-736330D2-17F9-4F42-827A-16597E5552B4Q28193254-8BD4F43D-7D6B-47B0-AC37-4453931C3CA9Q28574043-518D3256-F43D-468B-8786-72C5528242A8Q34067248-B596429B-A0AE-4AA4-8D51-D6421BE9C0A0Q34082384-CCBF3F6C-C1AC-4DB4-97E4-840EC1BE4E6CQ34253944-45E02A6D-1CE8-4C17-B4F1-CFAA042F09BDQ34746895-DFCAD7F6-E274-4A73-9E4A-455FB5FB95B2Q34969789-61A98CC7-C2C2-4AFC-ACC6-908C1DE2C278Q35011895-8ECA43D8-5807-440E-AECB-52151B5BFFC4Q35089196-E06C5EC9-80C7-41D5-9C05-FD2E66AD1EF4Q35147941-403E914A-E542-4FC1-AA84-DCED1BB98981Q35191271-BB5E47F5-78D6-4EC8-A7DA-E5ECF0821447Q35735316-A242AAEC-BEE5-44D0-A25C-B2866C584A4AQ35846025-A8FB2FC2-3753-43D9-AB11-58C6E9F5B67AQ36740041-280B570F-A2D9-465B-A445-32FBBD216524Q36753433-32A52C4C-5AA8-4740-9A41-D98A721AA575Q37263499-3A3E0D68-C142-4632-B3C6-DAF27F25D460Q37274380-9A507183-19A8-42F6-BDEC-E949BEC9BB77Q37625129-C26CB893-CE24-4E33-884F-E9265BF65DF5Q37725460-ED7A3984-5DE1-49B0-8D96-3DD304C34556Q38051084-29150A93-90BD-4D71-BAE1-5C0217BCD74FQ38111723-7659739F-055F-4B26-9815-1A1F74BBED2CQ38297445-C6A277D6-DA4B-4368-845F-886261EBB50AQ38710399-77ACDD3B-551F-4D5E-89AF-82060E83ED16Q38907143-F168DB3D-30D2-4396-A230-B2381297DD19Q39512060-4AE4DC2B-1E67-4C55-82C1-3413FCA017D7Q39879523-0E266CD9-5B0E-4E06-B533-CDA8D171CCF1Q40106311-79C7C307-960F-4778-BCDF-BE98341492A2Q40341822-17B190DF-029A-4A29-BC8B-983B43F5B8CEQ40578128-9C24CB96-CB38-49A0-A471-546C00678634Q40625598-6323DC40-BF43-42A6-A86D-A9314EEEBE84Q40685221-9BCAA8D1-5BD4-4F8F-833B-5F51BBE789E6Q40696265-630D8BC8-8AF1-46CA-90E6-73F9EF9C55EEQ40841745-C33E3FB3-D084-4EB4-8962-AAB354D50040Q40854466-42558E4C-0EB3-4DC2-9284-26F38A11D505Q40917355-25A59060-897E-49A7-BA57-17A18580E1D6Q41868894-CE520E02-ADEC-414A-9BE9-06049CE1BA1E
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cyclooxygenase-1 and -2 isoenzymes.
@ast
Cyclooxygenase-1 and -2 isoenzymes.
@en
type
label
Cyclooxygenase-1 and -2 isoenzymes.
@ast
Cyclooxygenase-1 and -2 isoenzymes.
@en
prefLabel
Cyclooxygenase-1 and -2 isoenzymes.
@ast
Cyclooxygenase-1 and -2 isoenzymes.
@en
P2093
P1476
Cyclooxygenase-1 and -2 isoenzymes.
@en
P2093
P304
P356
10.1016/S1357-2725(98)00152-6
P577
1999-05-01T00:00:00Z